Xilio Therapeutics
33 hedge funds and large institutions have $52.2M invested in Xilio Therapeutics in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
58% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 12
61% less capital invested
Capital invested by funds: $133M → $52.2M (-$80.5M)
Holders
33
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$502K | |
| 2 | +$417K | |
| 3 | +$220K | |
| 4 |
Millennium Management
New York
|
+$146K |
| 5 |
B
Bailard
Foster City,
California
|
+$107K |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$1.03M | |
| 3 | -$812K | |
| 4 |
BlackRock
New York
|
-$735K |
| 5 |
State Street
Boston,
Massachusetts
|
-$229K |